how long have glp-1 been on the market North America Glucagon-Like Peptide-1 (GLP-1) Agonist GLP-1 Receptor Agonist Market Size
Description
Tirzepatide $117/mo Billed at cost per vial ($234-$494)
PMID: 30 CsordasG.ThomasA
Strategic Imperatives in a Shifting GLP-1 Market The GLP-1 market has exposed how quickly alternative channels like telehealth platforms and compounding pharmacies can scale and disrupt traditional brand management
The intent of this change is to drive improved health outcomes, which could have substantial benefits and downstream impacts, but if enacted, the proposed changes will expand coverage criteria, significantly impacting health plans in quick time
Not vague reassurances
